Tools commonly used in the Oncologists industry for day-to-day tasks and operations.

• PET scanners
• CT scanners
• MRI machines
• Ultrasound machines
• Biopsy needles
• Radiation therapy machines
• Chemotherapy drugs
• Immunotherapy drugs
• Blood tests
• Genetic testing

Common products and services typical of NAICS Code 621111-16, illustrating the main business activities and contributions to the market.

• Breast cancer treatment
• Lung cancer treatment
• Prostate cancer treatment
• Colorectal cancer treatment
• Pancreatic cancer treatment
• Leukemia treatment
• Lymphoma treatment
• Melanoma treatment
• Brain cancer treatment
• Ovarian cancer treatment

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Board Certification In Oncology: Board certification is a voluntary process that demonstrates a physician's expertise in a particular specialty. The American Board of Internal Medicine (ABIM) offers certification in medical oncology, hematology, and medical oncology/hematology. The American Board of Radiology (ABR) offers certification in radiation oncology. The American Osteopathic Board of Internal Medicine (AOBIM) offers certification in medical oncology and hematology.
• State Medical License: A state medical license is required to practice medicine in the United States. The requirements for obtaining a medical license vary by state, but typically include graduation from an accredited medical school, completion of a residency program, and passing a licensing exam. The Federation of State Medical Boards (FSMB) provides information on the requirements for medical licensure in each state.
• Drug Enforcement Administration (DEA) Registration: Oncologists who prescribe controlled substances must register with the DEA. The DEA registration process involves completing an application, paying a fee, and passing a background check.
• Clinical Trials Certification: The National Cancer Institute (NCI) offers a Clinical Trials Research Associate (CTRA) certification program for individuals involved in the conduct of clinical trials. The program includes coursework and an exam.
• HIPAA Compliance: The Health Insurance Portability and Accountability Act (HIPAA) sets national standards for the protection of individuals' medical records and other personal health information. Oncologists must comply with HIPAA regulations to protect patient privacy and avoid penalties. The Department of Health and Human Services (HHS) provides information on HIPAA compliance for healthcare providers.
• OSHA Compliance: The Occupational Safety and Health Administration (OSHA) sets standards for workplace safety, including exposure to hazardous chemicals and radiation. Oncologists must comply with OSHA regulations to protect themselves and their staff from workplace hazards. The OSHA website provides information on compliance requirements for healthcare providers.
• Medicare Enrollment: Oncologists who provide services to Medicare beneficiaries must enroll in the Medicare program. The enrollment process involves completing an application and meeting certain eligibility requirements. The Centers for Medicare and Medicaid Services (CMS) provides information on the Medicare enrollment process.
• Continuing Medical Education (CME): Oncologists must complete a certain number of CME credits each year to maintain their medical license and board certification. CME courses are designed to keep physicians up-to-date on the latest medical advances and treatment options. The Accreditation Council for Continuing Medical Education (ACCME) provides information on CME requirements and accredited courses.
• American Society Of Clinical Oncology (ASCO) Membership: The ASCO is a professional organization for oncologists that provides education, advocacy, and networking opportunities. Membership is voluntary but can provide access to resources and support for oncologists.
• National Comprehensive Cancer Network (NCCN) Membership: The NCCN is a nonprofit organization that provides guidelines for the treatment of various types of cancer. Membership is voluntary but can provide access to the latest treatment recommendations and research.
• American Association for Cancer Research (AACR) Membership: The AACR is a professional organization for cancer researchers that provides education, advocacy, and networking opportunities. Membership is voluntary but can provide access to resources and support for oncologists.
• American Society for Radiation Oncology (ASTRO) Membership: The ASTRO is a professional organization for radiation oncologists that provides education, advocacy, and networking opportunities. Membership is voluntary but can provide access to resources and support for oncologists.
• American College Of Radiology (ACR) Membership: The ACR is a professional organization for radiologists that provides education, advocacy, and networking opportunities. Membership is voluntary but can provide access to resources and support for oncologists who specialize in radiation oncology.
• American Society Of Hematology (ASH) Membership: The ASH is a professional organization for hematologists that provides education, advocacy, and networking opportunities. Membership is voluntary but can provide access to resources and support for oncologists who specialize in hematology.
• American Board Of Medical Specialties (ABMS) Maintenance Of Certification (MOC): The ABMS MOC program is a voluntary process that allows physicians to demonstrate their ongoing commitment to professional development and quality patient care. The program includes continuing education, practice improvement activities, and a periodic assessment of knowledge and skills.
• American Medical Association (AMA) Membership: The AMA is a professional organization for physicians that provides education, advocacy, and networking opportunities. Membership is voluntary but can provide access to resources and support for oncologists.
• Society for Immunotherapy Of Cancer (SITC) Membership: The SITC is a professional organization for cancer immunotherapy researchers and practitioners that provides education, advocacy, and networking opportunities. Membership is voluntary but can provide access to resources and support for oncologists who specialize in immunotherapy.
• American Society Of Clinical Pathology (ASCP) Certification: The ASCP offers certification in various areas of laboratory medicine, including molecular pathology and cytogenetics. Oncologists who specialize in pathology may benefit from obtaining ASCP certification.
• American College Of Surgeons (ACS) Membership: The ACS is a professional organization for surgeons that provides education, advocacy, and networking opportunities. Membership is voluntary but can provide access to resources and support for oncologists who specialize in surgical oncology.
• American Society Of Breast Surgeons (Asbrs) Membership: The ASBrS is a professional organization for breast surgeons that provides education, advocacy, and networking opportunities. Membership is voluntary but can provide access to resources and support for oncologists who specialize in breast cancer.

A concise historical narrative of NAICS Code 621111-16 covering global milestones and recent developments within the United States.

• The history of the Oncologists industry dates back to the early 20th century when radiation therapy was first introduced as a treatment for cancer. In the 1940s, chemotherapy was developed, which revolutionized cancer treatment. In the 1970s, the first bone marrow transplant was performed, and in the 1980s, the first monoclonal antibody was approved for cancer treatment. In recent years, there have been significant advancements in precision medicine, immunotherapy, and targeted therapies. In the United States, the Oncologists industry has seen a surge in demand due to the aging population and the increasing prevalence of cancer. In the 1990s, the National Cancer Institute launched the Cancer Genome Atlas, which led to a better understanding of the genetic basis of cancer. In the 2000s, the FDA approved the first targeted therapy for cancer, and in the 2010s, immunotherapy became a game-changer in cancer treatment. Overall, the Oncologists industry has come a long way in the past century, and the advancements in technology and research have led to better outcomes for cancer patients.

The anticipated future trajectory of the NAICS 621111-16 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The future outlook for the industry of Oncologists in the USA is positive. The demand for oncologists is expected to increase due to the aging population and the rising incidence of cancer. According to the American Cancer Society, the number of cancer survivors in the US is expected to increase to 22.1 million by 2030, which will require more oncologists to provide care. Additionally, advancements in technology and treatment options are expected to improve patient outcomes and increase the demand for oncologists. However, the industry may face challenges such as rising healthcare costs and a shortage of oncologists in certain regions. Overall, the industry is expected to grow in the coming years.

Recent groundbreaking advancements and milestones in the Oncologists industry, reflecting notable innovations that have reshaped its landscape.

• Immunotherapy: This innovative treatment uses the body's immune system to fight cancer cells. It has shown promising results in treating various types of cancer, including melanoma, lung cancer, and bladder cancer.
• Precision Medicine: This approach uses genetic testing to identify the specific genetic mutations that cause cancer in a patient. This allows for personalized treatment plans that target the specific mutations, leading to better outcomes.
• Liquid Biopsy: This non-invasive test detects cancer by analyzing a patient's blood sample for cancer cells or DNA. It is less invasive than traditional biopsies and can detect cancer at an earlier stage.
• CAR-T Therapy: This innovative treatment involves modifying a patient's T-cells to recognize and attack cancer cells. It has shown promising results in treating certain types of blood cancers.
• 3D Printing: This technology is being used to create customized implants and prosthetics for cancer patients. It allows for more precise and personalized treatment options.